Email this article 
Post a Comment Characteristics of lipid spectrum and functional liver tests in patients with nonalcoholic liver steatosis depending on degree of obesity during menopause
- Authors: Bulatova I.A.1, Sobol A.A.2, Gulyaeva I.L.1
-
Affiliations:
- E.A. Vagner Perm State Medical University
- Women's Health Clinic
- Issue: Vol 39, No 4 (2022)
- Pages: 26-32
- Section: Original studies
- URL: https://journals.rcsi.science/PMJ/article/view/110784
- DOI: https://doi.org/10.17816/pmj39426-32
- ID: 110784
Cite item
Full Text
Abstract
Objective. To study the blood lipid spectrum and functional liver tests in women with nonalcoholic liver steatosis (NALS) depending on the degree of obesity during menopause.
Materials and methods. Seventy patients with NALS and obesity (NALS-O-M) in menopause with the mean age of 49,9 ± 1,1 years including 24 with increased body mass index (BMI), 20 – with the degree 1 obesity, 18 – the degree 2 obesity and 8 – the degree 3 obesity were examined. The control group involved 30 practically healthy women in menopause without obesity. Blood serum cytolysis, cholestasis and lipid spectrum indicators were studied in both groups.
Results. According to the results of biochemical investigation, in the group of patients with NALS-O-M syndrome no cytolysis was observed. In case of marked obesity, cholestasis syndrome by the blood alkaline phosphatase level was identified. Lipid spectrum in patients with NALS-O-M statistically significantly differed from the control: hypercholesterinemia, hypertriglyceridemia, increase in the low- and very low-density lipoproteins as well as calculated index of atherogeneity with decrease in the high-density lipoproteins fraction was registered.
Conclusions. A pronounced obesity causes the cholestasis syndrome with an increase in the blood alkaline phosphatase level. Dyslipidemia of different degree of manifestation is registered in all patients with steatosis and obesity during menopause, being more marked in patients with the degree 2–3 obesity.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
I. A. Bulatova
E.A. Vagner Perm State Medical University
Email: bula.1977@mail.ru
ORCID iD: 0000-0002-7802-4796
MD, PhD, Head of Department of Normal Physiology, Professor of Department of Faculty Therapy №2, Occupational Pathology and Clinical Laboratory Diagnostics
Russian Federation, PermA. A. Sobol
Women's Health Clinic
Email: bula.1977@mail.ru
therapeutist, gastroenterologist
Russian Federation, PermI. L. Gulyaeva
E.A. Vagner Perm State Medical University
Author for correspondence.
Email: bula.1977@mail.ru
ORCID iD: 0000-0001-7521-1732
MD, PhD, Professor, Head of Department of Pathologic Physiology
Russian Federation, PermReferences
- Drapkina O.M., Ivashkin V.T. Epidemiological features of non-alcoholic fatty liver disease in Russia (results of an open multicenter prospective follow-up study DIREGL 01903). Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii 2014; 4 (24): 32–38 (in Russian).
- Li Z. T., Ji F., Han X,W., Wang L., Yue Y.Q., Wang Z.G. The Role of Gastroesophageal Reflux in Provoking High Blood Pressure Episodes in Patients with Hypertension. Journal of Clinical Gastroenterology 2018; 8 (52): 685–690.
- Younossi Z.M., Koenig А.В., Abdelatif D. et al. Global epidemiology of nonalcoholic fatty liver disease – meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 1 (64): 73–84.
- Lazebnik L.B., Golovanova U.V., Turkina S.V. Non-alcoholic fatty liver disease in adults: clinic, diagnosis, treatment. Recommendations for therapists, the third version. Eksperimental'naya i klinicheskaya gastroenterologiya 2021; 1 (1): 4–52 (in Russian).
- Krolevets T. S., Livzan M.A. Clinical and laboratory markers for predicting liver fibrosis in individuals with non-alcoholic fatty liver disease. Eksperimental'naya i klinicheskaya gastroenterologiya 2018; 7 (155): 43–51 (in Russian).
- Gulyaeva I.L., Miftakhova A.M., Bulatova I.A., Kurtsev B.V. Pathogenetic justification of the use of Dzhigurda Procumbens for the prevention of the development of non-alcoholic liver steatosis (experimental study). Mezhdunarodnyy nauchno-issledovatel'skiy zhurnal 2021; 8 (110): 100–105, available at: https:// research-journal.org/wp-content/uploads/2021/ 08/8-110-2.pdf.
- Miftakhova A.M., Gulyaeva I.L., Bulatova I.A. Dynamics of functional liver tests on an experimental animal model against the background of taking Jinuri Procumbens. Nauka i innovatsii-sovremennye kontseptsii: sbornik nauchnykh statey po itogam raboty mezhdunarodnogo nauchnogo foruma 2021; 48–51 (in Russian).
- Miftakhova A.M., Gulyaeva I.L., Bulatova I.A. The effect of the aqueous extract of Jinura Procumbens on the lipid spectrum against the background of experimental liver steatosis. Vysshaya shkola: nauchnye issledovaniya: sbornik mezhvuzovskogo mezhdunarodnogo kongressa 2021; 92–96 (in Russian).
